Trulicity and Cipro drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Trulicity (dulaglutide) and Cipro (ciprofloxacin hydrochloride). Common drug interactions include infusion site irritation among females and necrotising fasciitis among males.
The phase IV clinical study analyzes what interactions people have when they take Trulicity and Cipro. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.
What is Trulicity?
Trulicity has active ingredients of dulaglutide. It is often used in weight loss. eHealthMe is studying from 77,529 Trulicity users. Check the latest studies of Trulicity.
What is Cipro?
Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 35,126 Cipro users. Check the latest studies of Cipro.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
48 people who take Trulicity and Cipro together, and have interactions are studied.

What are the common drug interactions of Trulicity and Cipro, by gender? *:
female:
- Infusion site irritation
- Injection site discolouration
- Injection site irritation
- Injection site pruritus (severe itching at injection site)
- Injection site rash
- Irritable bowel syndrome
- Joint dislocation (a joint position is changed from normal position)
- Lethargy (tiredness)
- Limb injury
- Lipase increased
male:
- Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
- Perineal abscess
- Abscess limb (limb infection)
- Anal abscess
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Bone density decreased
- Cellulitis of male external genital organ (infection of male genitals soft tissue)
- Cerebral thrombosis (blood clot in brain)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
What are the common drug interactions of Trulicity and Cipro, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
- Perineal abscess
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Anal abscess
- Cellulitis (infection under the skin)
- Chills (felling of cold)
- Nausea (feeling of having an urge to vomit)
- Nerve injury
- Pain
- Pyrexia (fever)
50-59:
- Abdominal discomfort
- Abdominal pain
- Chronic kidney disease
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Lipase increased
- Malaise (a feeling of general discomfort or uneasiness)
- Oropharyngeal pain
- Pancreatitis (inflammation of pancreas)
- Renal failure (kidney dysfunction)
- Vomiting
60+:
- Weight decreased
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Therapeutic response unexpected
- Abscess limb (limb infection)
- Adverse event
- Anaemia (lack of blood)
- Asthma
- Cellulitis (infection under the skin)
- Cellulitis of male external genital organ (infection of male genitals soft tissue)
- Cerebral thrombosis (blood clot in brain)
What are the existing conditions these people have? *
- Immunodeficiency Common Variable: 9 people, 18.75%
- Type 2 Diabetes: 5 people, 10.42%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 8.33%
- Diabetes: 4 people, 8.33%
- Circadian Rhythm Sleep Disorder (family of sleep disorders affecting, among other things, the timing of sleep): 4 people, 8.33%
- Weight Decreased: 3 people, 6.25%
- Hidradenitis (chronic disease of a type of sweat gland): 3 people, 6.25%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 6.25%
- Essential Thrombocythaemia (chronic blood cancer): 3 people, 6.25%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Trulicity and Cipro?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Trulicity and Cipro:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Trulicity:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cipro:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Trulicity and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cipro and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on dulaglutide and ciprofloxacin hydrochloride (the active ingredients of Trulicity and Cipro, respectively), and Trulicity and Cipro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cymbalta cause Papilloma? - 9 seconds ago
- Could Osphena cause Memory Loss? - 13 seconds ago
- Could Irbesartan cause Limb Injury? - 19 seconds ago
- Could Cymbalta cause Breast Infection? - 21 seconds ago
- Could Myrbetriq cause Loss Of Control Of Legs? - 27 seconds ago
- Could Ipratropium Bromide cause Tremor? - 29 seconds ago
- Could Trospium Chloride cause Neck Pain? - 34 seconds ago
- Could Alendronate Sodium cause Flatulence? - 35 seconds ago
- Could Alendronate Sodium cause Multi-Organ Failure? - 36 seconds ago
- Could Oruvail cause Hypotension? - 41 seconds ago